SlideShare a Scribd company logo
1 of 29
Download to read offline
eSubmissions in Australia 
Part 2 
Dr John Donohoe Director, Knowledge Management Section Office of Medicines Authorisation 16 December 2014
Regional Content 
• 
Module 1 administrative and prescribing information 
• 
Module 2.3.R and 3.2.R regional information 
– 
2.3.R should provide a brief description of the information provided under 3.2.R 
– 
Applicants should include the following information in Module 3.2.R, where appropriate: 
§ 
Process validation scheme for the drug product 
§ 
Certificates of suitability 
§ 
Risk of transmitting animal spongiform encephalopathy agents 
§ 
Certified Product Details 
§ 
Supplier’s declarations regarding compliance with packaging standards and colouring standards. eSubmissions in Australia 1
Node Extensions 
• 
A way of providing extra organisational information to the eCTD. 
• 
Visualised as an extra heading in the CTD structure. 
• 
Displayed as extra headings when the XML backbone is viewed. 
• 
Node-extension structure is in compliance with general ICH eCTD specifications 
• 
Example: Grouping multiple files belonging to a single study 
– 
5312 (eCTD Section) 
§ 
Study ABC123 
• 
Synopsis.pdf 
• 
Report Body.pdf 
• 
Discontinued Patient Listing.pdf 
§ 
Study XYZ321 
• 
Synopsis.pdf 
• 
Report Body.pdf 
• 
Discontinued Patient Listing.pdf 
– 
537 CRFs 
§ 
Study ABC123 
‒ 
Site 123 
• 
CRF-123-0001.pdf 
• 
CRF-123-0002.pdf 
‒ 
Site 234 
• 
CRF-234-0001.pdf 
• 
CRF-234-0002.pdf eSubmissions in Australia 
2
Node Extensions and Leaf Elements 
• 
Structures beyond the heading elements can be defined through node extension elements. 
• 
Content for each heading element is provided through leaf elements. 
• 
Wherever a leaf element is allowed in the schema, a node-extension element is also allowed. 
• 
The optional node-extension element contains a single mandatory title element, followed by at least one leaf element. 
• 
The node extension title element and leaf title element should be short, precise and informative. 
– 
Information already categorized by heading elements need not be repeated. 
– 
The most important identifying information should be placed at the beginning to prevent reviewers from having to scroll to the end of the title. 
eSubmissions in Australia 
3
Node Extensions 
• 
Node Extension structures should be considered and used where needed to assist reviewers 
• 
Consider the impact of changing node extension structures during the lifecycle 
• 
Don’t use where ICH specified sub headings already exist 
• 
Only use at the lowest level of the eCTD structure 
• 
Use to group together multiple like documents 
• 
Node extensions may be nested 
• 
Node extensions content can be placed in separate sub folders 
eSubmissions in Australia 
4
Leaf Titles 
• 
The display name given to a document and will be shown to the evaluator 
• 
An evaluator never sees the file/folder names in the file structure 
• 
Leaf titles should not include: 
– 
file extensions, e.g. appendix1.pdf 
– 
hyphens or underscores, e.g. copy-certification.pdf 
– 
eCTD section number. 
The eCTD application has “life cycle” and contains the history of all your submissions! eSubmissions in Australia 5
Study Tagging Files 
• 
A structured solution to organizing studies in eCTD applications providing a consistent structure for review and categorisation of clinical and nonclinical studies. 
• 
Comprised of an XML Backbone file with category information and links to study content. 
• 
Content tags based on ICH E3 Guidance on the Structure of Clinical Studies. 
• 
Predefined values for Species, Route of Administration, Duration and Type of Control. 
• 
TGA does not currently have any plans to mandate study tagging files (STFs) for evaluation purposes. 
• 
Applicants wishing to reuse content submitted in other regions where STFs have been used can do so. 
• 
If provided, STFs will be validated and must be conform to standards and specifications. eSubmissions in Australia 
6
Regional File Formats 
• 
Module 1 – Both PDF and XML have been designated as acceptable file formats for the AU Module 1. 
– 
No structured exchange (XML) standards for content are currently defined 
– 
These may be introduced in the future for content such as the lifecycle management tracking table, application forms, etc. 
– 
All PDF files included in an eCTD irrespective of the module should be v1.4, v1.5, v1.6 or v1.7 except where a specific requirement for a later version is defined 
– 
It is preferred that PDFs be generated from an electronic source. Signatures may be embedded as a graphic file in the PDF text if desired. 
• 
Modules 2 to 5 - No additional file formats are defined for Modules 2 to 5 other than those mentioned in the ICH eCTD Specification Document. eSubmissions in Australia 
7
Use of Electronic Signatures 
• 
Currently the use of digital signatures for electronic submissions is not fully supported within the TGA. 
• 
Scanned signatures would ordinarily be used where the documents make up part of the checksum of an eCTD submission. 
eSubmissions in Australia 
8
Handling of Empty or Missing eCTD Sections 
• 
For new applications, including generic applications, detailed statements justifying the absence of data or specific CTD sections should be provided in the relevant Quality Overall Summary and/or Nonclinical/Clinical Overviews e.g. Module 2.3, 2.4, or 2.5. 
• 
For a generic application, there is no need to provide a justification for content that is typically absent. 
• 
Note that placeholder documents highlighting no relevant content should not be placed in the eCTD structure. eSubmissions in Australia 
9
Updating Backbone Attributes 
• 
Updating ICH attributes 
– 
Updating XML backbone attributes such as manufacturer during the eCTD lifecycle is possible. 
– 
Consideration should be given regarding the impact of changing backbone attributes during the lifecycle. 
– 
Changes can lead to a higher level of complexity in the cumulative view of a submission. 
• 
Updating AU envelope information 
– 
The AU envelope information can be updated during the lifecycle as is necessary to reflect changes in the application metadata. 
eSubmissions in Australia 
10
File Reuse 
• 
TGA accepts and encourages applicants to make active use of file reuse. 
• 
Applicants should not submit the same document multiple times. 
• 
File reuse should be used when 
– 
a file is submitted multiple times within one sequence, 
– 
a file already submitted in an earlier sequence is being referenced again, 
– 
or if a file submitted in another application is being referenced in a new application. 
• 
TGA is implementing a flat repository structure to make cross application referencing possible. 
– 
Links to content provided in other applications simply need to be directed out of the current application structure and into the structure of the corresponding application. 
– 
All application will be stored using the eSubmission Identifier to make cross referencing easily predictable and possible. 
eSubmissions in Australia 
11
Module 1 Architecture 
The AU Module 1 Backbone File and Style-Sheet 
• 
The Australian Module 1 is schema based instead of using a dtd. 
• 
The Australian Module 1 eCTD backbone file comprises three main components: 
– 
A fixed eXtensible Markup Language (XML) root element; 
– 
The envelope elements; and 
– 
The eCTD heading elements describing the actual files provided. 
• 
Style-Sheet 
– 
A standard style-sheet is provided that can be used to view content 
– 
The style-sheet has been designed to display the complete Module 1 
– 
The style-sheet is not part of the specification package 
– 
eCTD applications can be submitted with or without the style-sheet 
– 
The TGA will not be reviewing content using the style-sheet 
– 
Its existence is not part of the validation criteria eSubmissions in Australia 
12
Module 1 Architecture 
XML Root Element 
• 
All Australian Module 1 backbone files prepared for the TGA will contain the standard XML root element 
• 
The required text includes an XML declaration and the root element tga_ectd with its attributes linking the XML file to the XML definition prepared by the TGA 
• 
Without style-sheet: 
•With style-sheet: eSubmissions in Australia 
13
Envelope Elements 
• 
What are Envelope Elements? 
– 
Administrative information imbedded into a sequence which helps to identify and categorise the content, also for automated processes. 
XML Element 
Description 
Constraint 
Occurrence 
Defined List 
esub-id 
eSubmission Identifier 
Mandatory 
Single 
applicant 
Applicant 
Mandatory 
Single 
aan 
Australian Approved Name(s) 
Mandatory 
Multiple 
product-name 
Product Name 
Mandatory 
Multiple 
artg-number 
ARTG Number 
Optional 
Multiple 
sequence-description 
Sequence Description 
Mandatory 
Single 
X 
sequence-number 
Sequence Number 
Mandatory 
Single 
related-sequence-number 
Related Sequence Number 
Optional 
Single 
reg-activity-lead 
Regulatory Activity Lead 
Mandatory 
Single 
X 
sequence-type 
Sequence Type 
Mandatory 
Single 
X eSubmissions in Australia 
14
Envelope Elements: Defined Lists 
• 
The defined lists are provided and maintained as separate XML files 
• 
Each file contains a standard set of codes for the corresponding envelope element. 
• 
Codes have been implemented to reduce validation issues 
• 
The code definition files contain a version number, version date and coded values as well as plain texts for each value. 
• 
Only the plain text value is shown to the reviewers in the review system. 
• 
Defined lists have been created for 
– 
Sequence Description 
– 
Regulatory Activity Lead 
– 
Sequence Type eSubmissions in Australia 
15
Envelope Elements: Sequence Description 
• 
The sequence description defined list of codes and values is available from http://tga.gov.au/downloads/sequence-description.xml. Applicants should refer to this list for current list values. 
• 
There are 4 types of sequence description approaches 
– 
Some values can be used without further information 
– 
Others will require the description to be combined with a date 
– 
In the example with the PSUR, both the start date and the end date have to be entered 
– 
Finally, some descriptions will need additional information added in the form of a brief description (brief – under 40 characters) eSubmissions in Australia 
16
Envelope Elements 
Sequence Description Example 1 
Some values can be used without further information e.g. Initial. 
– 
The code for “Initial” is seq-desc-2 as specified in the defined list 
– 
Note that the code version must be specified as an attribute code-version of the sequence-description element. eSubmissions in Australia 
17
Envelope Elements 
Sequence Description Example 2 
Others will require the description to be combined with a date e.g. Response to Screening Clarification Request – 2014-03-30. 
– 
The code for a response to a screening clarification request is seq-desc-5 as specified in the defined list 
– 
Response to Screening Clarification Request - {date:d} 
– 
A date is required as additional data. The name of the placeholder is date. It requires an actual value in date format (because of the letter d following the colon). 
eSubmissions in Australia 
18
Envelope Elements 
Sequence Description Example 3 
In the example with the PSUR, both the start date and the end date will have to be entered e.g. PSUR for Period of 2015-01-01 to 2015-06-30. 
– 
The code for “PSUR” is seq-desc-20 as specified in the defined list 
– 
PSUR for Period of {from-date:d} to {to-date:d} 
– 
Two placeholders have been specified. The first one is named from-date and the second one is named to-date eSubmissions in Australia 
19
Envelope Elements 
Sequence Description Example 4 
Finally, some descriptions will need additional information added in the form of a brief description (brief – under 40 characters) e.g. Uncategorised, DESCRIPTION. 
– 
The code for “uncategorized” is seq-desc-24 as specified in the defined list 
– 
Uncategorised, {description:s} 
– 
The name of the placeholder is description. It requires an actual value in plain text format which is indicated by the letter “s” following the colon. eSubmissions in Australia 
20
Envelope Elements 
Regulatory Activity Lead 
The regulatory activity lead defined list of codes and values is managed at http://tga.gov.au/downloads/reg-activity-lead.xml. Applicants should refer to this list for current list values. 
The code for “Prescription” is reg-act-lead-6 as specified in the defined list 
Note that the code version must be specified as an attribute code-version of the reg-activity-lead element. eSubmissions in Australia 
21
Envelope Elements 
Sequence Type 
The sequence type defined list of codes and values is available from http://tga.gov.au/downloads/sequence-type.xml. Applicants should refer to this list for current list values. 
The code for “New chemical entities” is seq-type-1 as specified in the defined list 
Note that the code version must be specified as an attribute code-version of the sequence-type element. eSubmissions in Australia 
22
Heading Elements 
What are Heading Elements? 
• 
Each specified section of the eCTD is associated with a heading element which is used to identify and organise the content associated with that section. eSubmissions in Australia 
23
Heading Elements 
Section ID 
Business Terminology 
XML-Element 
1.0 
Correspondence 
m1-0-correspondence 
1.0.1 
Cover letter 
m1-0-1-cover 
1.0.2 
Lifecycle management tracking table 
m1-0-2-tracking-table 
1.0.3 
Response to request for information 
m1-0-3-response 
1.2 
Administrative Information 
m1-2-admin-info 
1.2.1 
Application forms 
m1-2-1-app-form 
1.2.2 
Pre-submission details 
m1-2-2-pre-sub-details 
1.2.3 
Patent certification 
m1-2-3-pat-cert 
1.2.4 
Change in sponsor 
m1-2-4-change-sponsor 
1.3 
Medicine information and labelling 
m1-3-med-info 
1.3.1 
Product information and package insert 
m1-3-1-pi 
1.3.1.1 
Product information - clean 
m1-3-1-1-pi-clean 
1.3.1.2 
Product information - annotated 
m1-3-1-2-pi-annotated 
1.3.1.3 
Package insert 
m1-3-1-3-pack-ins 
1.3.2 
Consumer medicines information 
m1-3-2-cmi 
1.3.2.1 
Consumer medicines information - clean 
m1-3-2-1-cmi-clean 
1.3.2.2 
Consumer medicines information - annotated 
m1-3-2-2-cmi-annotated 
1.3.3 
Label mock-ups and specimens 
m1-3-3-mockup 
Section ID 
Business Terminology 
XML-Element 
1.4 
Information about the experts 
m1-4-experts 
1.4.1 
Quality 
m1-4-1-quality 
1.4.2 
Nonclinical 
m1-4-2-nonclinical 
1.4.3 
Clinical 
m1-4-3-clinical 
1.5 
Specific requirements for different types of applications 
m1-5-specific 
1.5.1 
Literature-based submission documents 
m1-5-1-lit-based 
1.5.2 
Orphan drug designation 
m1-5-2-orphan 
1.5.3 
Genetically modified organisms consents 
m1-5-3-gmo 
1.5.4 
Additional trade name declarations 
m1-5-4-trade-name 
1.5.5 
Co-marketed medicines declarations 
m1-5-5-co-marketed 
1.5.6 
Combination medicine consent 
m1-5-6-comb-med 
1.5.7 
OTC product assurances 
m1-5-7-prod-assurance 
1.5.8 
Analytical validation summary 
m1-5-8-analyt-val-sum 
1.6 
Master files and certificates of suitability 
m1-6-master-files 
1.6.1 
Relevant external sources 
m1-6-1-ext-sources 
1.6.2 
Applicant's declaration 
m1-6-2-app-decl 
1.6.3 
Letters of access 
m1-6-3-loa 
eSubmissions in Australia 
24
Heading Elements 
Section ID 
Business Terminology 
XML-Element 
1.7 
Compliance with meetings and pre- submission processes 
m1-7-compliance 
1.7.1 
Details of compliance with pre-submission meeting outcomes 
m1-7-1-pre-sub 
1.7.2 
Details of any additional data to be submitted 
m1-7-2-add-data 
1.7.3 
Declaration of compliance with pre-submission planning form and planning letter 
m1-7-3-planning 
1.8 
Information relating to pharmacovigilance 
m1-8-pv 
1.8.1 
Pharmacovigilance systems 
m1-8-1-pv-systems 
1.8.2 
Risk management plan 
m1-8-2-risk 
1.9 
Summary of biopharmaceutic studies 
m1-9-biopharm 
1.9.1 
Summary of bioavailability or bioequivalence study 
m1-9-1-ba-be 
1.9.2 
Justification for not providing biopharmaceutic studies 
m1-9-2-justification 
1.10 
Information relating to paediatrics 
m1-10-paediatrics 
1.11 
Foreign regulatory information 
m1-11-foreign 
1.11.1 
Foreign regulatory status 
m1-11-1-status 
1.11.2 
Foreign product information 
m1-11-2-pi 
1.11.3 
Data similarities and differences 
m1-11-3-similarities 
1.11.4 
Foreign evaluation reports 
m1-11-4-eval-reports 
1.12 
Antibiotic resistance data 
m1-12-antibiotic 
eSubmissions in Australia 
25
Module 1 Architecture 
Files and Folders 
• 
Naming conventions for the content files are irrelevant for electronic review. 
• 
All content must be referenced by the appropriate XML files for efficient navigation. 
• 
Applicants should concentrate on providing precise but informative leaf titles to aid reviewers. 
Folder 
File 
Description 
e123456 
Application folder with eSubmission identifier e.g. e123456 
0000 
Sequence folder with four digit sequence number e.g. 0000 
index.xml 
Index file in accordance with ICH 
index-md5.txt 
MD5 checksum in accordance with ICH 
m1 
Content folder for Module 1 documents in accordance with ICH 
au 
Australia country specific folder 
au-regional.xml 
Australia regional index file for Module 1 
m2 
Content folder for Module 2 documents in accordance with ICH 
m3 
Content folder for Module 3 documents in accordance with ICH 
m4 
Content folder for Module 4 documents in accordance with ICH 
m5 
Content folder for Module 5 documents in accordance with ICH 
util 
Util folder in accordance with ICH 
dtd 
DTD and schema folder in accordance with ICH 
au-regional.xsd 
Australia regional backbone schema for Module 1 
xlink.xsd 
W3C schema for XLink 1.1 (referenced from au-regional.xsd) 
xml.xsd 
W3C schema for XML namespace (referenced from au-regional.xsd) 
ich-ectd-3-2.dtd 
ICH DTD for Modules 2 to 5 
style 
Style sheet folder in accordance with ICH (optional) 
ectd-2-0.xsl 
ICH style sheet for Modules 2 to 5 (optional) 
au-regional.xsl 
Style sheet for Australian regional backbone (optional) 
0000-validation-report 
Comprehensive output from an eCTD validation tool eSubmissions in Australia 
26
The Final Take Away 
Consider Your Audience: 
•If you were the evaluator and you are not familiar with the submission, could you easily navigate the submission and do an efficient review? 
•Perform an overall QC after compiling the submission. 
•Navigate the submission using eCTD TOC tree, leaf titles, links, and bookmarks keeping the evaluator in mind. 
•Use a QC process or checklist to help ensure submissions don’t contain formatting issues. 
•Good planning and being proactive can help you avoid the need to respond to queries, send resubmissions, and send additional corrective submissions to fix formatting issues! eSubmissions in Australia 27
Presentation: eSubmissions in Australia - Part 2

More Related Content

What's hot

eCTD Submission process diagramm
eCTD Submission process diagrammeCTD Submission process diagramm
eCTD Submission process diagrammV E R A
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESVikas Rathee
 
Preparing Compliant eCTD Submissions
Preparing Compliant eCTD SubmissionsPreparing Compliant eCTD Submissions
Preparing Compliant eCTD SubmissionsScott Abel
 
CTD and eCTD Format
CTD and eCTD Format CTD and eCTD Format
CTD and eCTD Format NikhilThorane
 
US DMF v/s European DMF
US DMF v/s European DMFUS DMF v/s European DMF
US DMF v/s European DMFNeha Pillai
 
EU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGESEU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGESChandra Mohan
 
The Regulation Of Medical Device In China
The Regulation Of Medical Device In ChinaThe Regulation Of Medical Device In China
The Regulation Of Medical Device In ChinaJacobe2008
 
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...eCTDconsultancy
 
Drug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptxDrug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptxbhavuk11
 
EU REGULATORY SUBMISSIONS
EU REGULATORY SUBMISSIONSEU REGULATORY SUBMISSIONS
EU REGULATORY SUBMISSIONSChandra Mohan
 
Documentation in Pharmaceutical Industry.pptx
Documentation in Pharmaceutical Industry.pptxDocumentation in Pharmaceutical Industry.pptx
Documentation in Pharmaceutical Industry.pptxAartiVats5
 
Guidance for Industry on Providing Regulatory Information in eCTD Format
Guidance for Industry on Providing Regulatory  Information in eCTD Format Guidance for Industry on Providing Regulatory  Information in eCTD Format
Guidance for Industry on Providing Regulatory Information in eCTD Format Cláudio Carneiro
 
Electronic submission PPT
Electronic submission PPTElectronic submission PPT
Electronic submission PPTDoninder Hooda
 

What's hot (20)

DMF by Anthony Crasto
DMF by Anthony CrastoDMF by Anthony Crasto
DMF by Anthony Crasto
 
eCTD Submission process diagramm
eCTD Submission process diagrammeCTD Submission process diagramm
eCTD Submission process diagramm
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
 
Preparing Compliant eCTD Submissions
Preparing Compliant eCTD SubmissionsPreparing Compliant eCTD Submissions
Preparing Compliant eCTD Submissions
 
CTD and eCTD Format
CTD and eCTD Format CTD and eCTD Format
CTD and eCTD Format
 
US DMF v/s European DMF
US DMF v/s European DMFUS DMF v/s European DMF
US DMF v/s European DMF
 
EU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGESEU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGES
 
The Regulation Of Medical Device In China
The Regulation Of Medical Device In ChinaThe Regulation Of Medical Device In China
The Regulation Of Medical Device In China
 
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
 
China: Medical Device Regulations
China: Medical Device RegulationsChina: Medical Device Regulations
China: Medical Device Regulations
 
Regulatory requirement on dossier of medicinal products
Regulatory requirement on dossier of medicinal productsRegulatory requirement on dossier of medicinal products
Regulatory requirement on dossier of medicinal products
 
CTD and eCTD
CTD and eCTDCTD and eCTD
CTD and eCTD
 
Drug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptxDrug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptx
 
GHTF study group 3
GHTF study group 3GHTF study group 3
GHTF study group 3
 
EU REGULATORY SUBMISSIONS
EU REGULATORY SUBMISSIONSEU REGULATORY SUBMISSIONS
EU REGULATORY SUBMISSIONS
 
Documentation in Pharmaceutical Industry.pptx
Documentation in Pharmaceutical Industry.pptxDocumentation in Pharmaceutical Industry.pptx
Documentation in Pharmaceutical Industry.pptx
 
Guidance for Industry on Providing Regulatory Information in eCTD Format
Guidance for Industry on Providing Regulatory  Information in eCTD Format Guidance for Industry on Providing Regulatory  Information in eCTD Format
Guidance for Industry on Providing Regulatory Information in eCTD Format
 
Electronic submission PPT
Electronic submission PPTElectronic submission PPT
Electronic submission PPT
 
Good distribution practices white paper
Good distribution practices  white paperGood distribution practices  white paper
Good distribution practices white paper
 
CTD & E-CTD
CTD & E-CTDCTD & E-CTD
CTD & E-CTD
 

Similar to Presentation: eSubmissions in Australia - Part 2

eCTD in Australia and Experience in the Pilot Programme
eCTD in Australia and Experience in the Pilot ProgrammeeCTD in Australia and Experience in the Pilot Programme
eCTD in Australia and Experience in the Pilot ProgrammeTGA Australia
 
Presentation: Electronic submissions - New specifications experiences and cha...
Presentation: Electronic submissions - New specifications experiences and cha...Presentation: Electronic submissions - New specifications experiences and cha...
Presentation: Electronic submissions - New specifications experiences and cha...TGA Australia
 
Electronic submission requirements for prescription medicines - AU eCTD update
Electronic submission requirements for prescription medicines - AU eCTD updateElectronic submission requirements for prescription medicines - AU eCTD update
Electronic submission requirements for prescription medicines - AU eCTD updateTGA Australia
 
Presentation: eSubmissions in Australia - Part 1
Presentation: eSubmissions in Australia - Part 1Presentation: eSubmissions in Australia - Part 1
Presentation: eSubmissions in Australia - Part 1TGA Australia
 
Chpt 4 SRS.pptx
Chpt 4 SRS.pptxChpt 4 SRS.pptx
Chpt 4 SRS.pptxMitiku33
 
Chpt 4 SRS.pptx
Chpt 4 SRS.pptxChpt 4 SRS.pptx
Chpt 4 SRS.pptxMitiku33
 
(ATS3-DEV04) Introduction to Pipeline Pilot Protocol Development for Developers
(ATS3-DEV04) Introduction to Pipeline Pilot Protocol Development for Developers(ATS3-DEV04) Introduction to Pipeline Pilot Protocol Development for Developers
(ATS3-DEV04) Introduction to Pipeline Pilot Protocol Development for DevelopersBIOVIA
 
2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange
2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange
2013 OHSUG - Integration of Argus and Other Products Using the E2B InterchangePerficient
 
Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)Md. Zakaria Faruki
 
TMF-Reference-Model-Presentation.pptx
TMF-Reference-Model-Presentation.pptxTMF-Reference-Model-Presentation.pptx
TMF-Reference-Model-Presentation.pptxJaimeHinojosa18
 
Ica Adri Module 2 Presentation Kl Stephen Clarke
Ica Adri Module 2 Presentation Kl Stephen ClarkeIca Adri Module 2 Presentation Kl Stephen Clarke
Ica Adri Module 2 Presentation Kl Stephen ClarkeStephenClarke
 
IRJET- Resume Information Extraction Framework
IRJET- Resume Information Extraction FrameworkIRJET- Resume Information Extraction Framework
IRJET- Resume Information Extraction FrameworkIRJET Journal
 
M.FLORENCE DAYANA WEB DESIGN -Unit 5 XML
M.FLORENCE DAYANA WEB DESIGN -Unit 5   XMLM.FLORENCE DAYANA WEB DESIGN -Unit 5   XML
M.FLORENCE DAYANA WEB DESIGN -Unit 5 XMLDr.Florence Dayana
 
Elements of Data Documentation
Elements of Data DocumentationElements of Data Documentation
Elements of Data Documentationssri-duke
 
Webinar: What's New in Pipeline Pilot 8.5 Collection Update 1?
Webinar: What's New in Pipeline Pilot 8.5 Collection Update 1?Webinar: What's New in Pipeline Pilot 8.5 Collection Update 1?
Webinar: What's New in Pipeline Pilot 8.5 Collection Update 1?BIOVIA
 
Migrating Clinical Data in Various Formats to a Clinical Data Management System
Migrating Clinical Data in Various Formats to a Clinical Data Management SystemMigrating Clinical Data in Various Formats to a Clinical Data Management System
Migrating Clinical Data in Various Formats to a Clinical Data Management SystemPerficient, Inc.
 
Designing and documenting software architecture unit 5
Designing and documenting software architecture unit 5Designing and documenting software architecture unit 5
Designing and documenting software architecture unit 5Sudarshan Dhondaley
 

Similar to Presentation: eSubmissions in Australia - Part 2 (20)

eCTD in Australia and Experience in the Pilot Programme
eCTD in Australia and Experience in the Pilot ProgrammeeCTD in Australia and Experience in the Pilot Programme
eCTD in Australia and Experience in the Pilot Programme
 
Presentation: Electronic submissions - New specifications experiences and cha...
Presentation: Electronic submissions - New specifications experiences and cha...Presentation: Electronic submissions - New specifications experiences and cha...
Presentation: Electronic submissions - New specifications experiences and cha...
 
Electronic submission requirements for prescription medicines - AU eCTD update
Electronic submission requirements for prescription medicines - AU eCTD updateElectronic submission requirements for prescription medicines - AU eCTD update
Electronic submission requirements for prescription medicines - AU eCTD update
 
ECTD BY NITESH
ECTD BY NITESHECTD BY NITESH
ECTD BY NITESH
 
eCTD
eCTDeCTD
eCTD
 
Presentation: eSubmissions in Australia - Part 1
Presentation: eSubmissions in Australia - Part 1Presentation: eSubmissions in Australia - Part 1
Presentation: eSubmissions in Australia - Part 1
 
Chpt 4 SRS.pptx
Chpt 4 SRS.pptxChpt 4 SRS.pptx
Chpt 4 SRS.pptx
 
Chpt 4 SRS.pptx
Chpt 4 SRS.pptxChpt 4 SRS.pptx
Chpt 4 SRS.pptx
 
(ATS3-DEV04) Introduction to Pipeline Pilot Protocol Development for Developers
(ATS3-DEV04) Introduction to Pipeline Pilot Protocol Development for Developers(ATS3-DEV04) Introduction to Pipeline Pilot Protocol Development for Developers
(ATS3-DEV04) Introduction to Pipeline Pilot Protocol Development for Developers
 
2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange
2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange
2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange
 
Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)
 
TMF-Reference-Model-Presentation.pptx
TMF-Reference-Model-Presentation.pptxTMF-Reference-Model-Presentation.pptx
TMF-Reference-Model-Presentation.pptx
 
Ica Adri Module 2 Presentation Kl Stephen Clarke
Ica Adri Module 2 Presentation Kl Stephen ClarkeIca Adri Module 2 Presentation Kl Stephen Clarke
Ica Adri Module 2 Presentation Kl Stephen Clarke
 
IRJET- Resume Information Extraction Framework
IRJET- Resume Information Extraction FrameworkIRJET- Resume Information Extraction Framework
IRJET- Resume Information Extraction Framework
 
M.FLORENCE DAYANA WEB DESIGN -Unit 5 XML
M.FLORENCE DAYANA WEB DESIGN -Unit 5   XMLM.FLORENCE DAYANA WEB DESIGN -Unit 5   XML
M.FLORENCE DAYANA WEB DESIGN -Unit 5 XML
 
Elements of Data Documentation
Elements of Data DocumentationElements of Data Documentation
Elements of Data Documentation
 
Webinar: What's New in Pipeline Pilot 8.5 Collection Update 1?
Webinar: What's New in Pipeline Pilot 8.5 Collection Update 1?Webinar: What's New in Pipeline Pilot 8.5 Collection Update 1?
Webinar: What's New in Pipeline Pilot 8.5 Collection Update 1?
 
Migrating Clinical Data in Various Formats to a Clinical Data Management System
Migrating Clinical Data in Various Formats to a Clinical Data Management SystemMigrating Clinical Data in Various Formats to a Clinical Data Management System
Migrating Clinical Data in Various Formats to a Clinical Data Management System
 
Designing and documenting software architecture unit 5
Designing and documenting software architecture unit 5Designing and documenting software architecture unit 5
Designing and documenting software architecture unit 5
 
eCTD
eCTDeCTD
eCTD
 

More from TGA Australia

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsTGA Australia
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesTGA Australia
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch TGA Australia
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateTGA Australia
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...TGA Australia
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateTGA Australia
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...TGA Australia
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesTGA Australia
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...TGA Australia
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchTGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchTGA Australia
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine ShortagesTGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2TGA Australia
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeTGA Australia
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA Australia
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchTGA Australia
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...TGA Australia
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Australia
 

More from TGA Australia (20)

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 

Recently uploaded

Governance and Nation-Building in Nigeria: Some Reflections on Options for Po...
Governance and Nation-Building in Nigeria: Some Reflections on Options for Po...Governance and Nation-Building in Nigeria: Some Reflections on Options for Po...
Governance and Nation-Building in Nigeria: Some Reflections on Options for Po...Kayode Fayemi
 
Thirunelveli call girls Tamil escorts 7877702510
Thirunelveli call girls Tamil escorts 7877702510Thirunelveli call girls Tamil escorts 7877702510
Thirunelveli call girls Tamil escorts 7877702510Vipesco
 
Call Girl Number in Khar Mumbai📲 9892124323 💞 Full Night Enjoy
Call Girl Number in Khar Mumbai📲 9892124323 💞 Full Night EnjoyCall Girl Number in Khar Mumbai📲 9892124323 💞 Full Night Enjoy
Call Girl Number in Khar Mumbai📲 9892124323 💞 Full Night EnjoyPooja Nehwal
 
CTAC 2024 Valencia - Sven Zoelle - Most Crucial Invest to Digitalisation_slid...
CTAC 2024 Valencia - Sven Zoelle - Most Crucial Invest to Digitalisation_slid...CTAC 2024 Valencia - Sven Zoelle - Most Crucial Invest to Digitalisation_slid...
CTAC 2024 Valencia - Sven Zoelle - Most Crucial Invest to Digitalisation_slid...henrik385807
 
Call Girls in Sarojini Nagar Market Delhi 💯 Call Us 🔝8264348440🔝
Call Girls in Sarojini Nagar Market Delhi 💯 Call Us 🔝8264348440🔝Call Girls in Sarojini Nagar Market Delhi 💯 Call Us 🔝8264348440🔝
Call Girls in Sarojini Nagar Market Delhi 💯 Call Us 🔝8264348440🔝soniya singh
 
BDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort ServiceDelhi Call girls
 
WhatsApp 📞 9892124323 ✅Call Girls In Juhu ( Mumbai )
WhatsApp 📞 9892124323 ✅Call Girls In Juhu ( Mumbai )WhatsApp 📞 9892124323 ✅Call Girls In Juhu ( Mumbai )
WhatsApp 📞 9892124323 ✅Call Girls In Juhu ( Mumbai )Pooja Nehwal
 
CTAC 2024 Valencia - Henrik Hanke - Reduce to the max - slideshare.pdf
CTAC 2024 Valencia - Henrik Hanke - Reduce to the max - slideshare.pdfCTAC 2024 Valencia - Henrik Hanke - Reduce to the max - slideshare.pdf
CTAC 2024 Valencia - Henrik Hanke - Reduce to the max - slideshare.pdfhenrik385807
 
Open Source Strategy in Logistics 2015_Henrik Hankedvz-d-nl-log-conference.pdf
Open Source Strategy in Logistics 2015_Henrik Hankedvz-d-nl-log-conference.pdfOpen Source Strategy in Logistics 2015_Henrik Hankedvz-d-nl-log-conference.pdf
Open Source Strategy in Logistics 2015_Henrik Hankedvz-d-nl-log-conference.pdfhenrik385807
 
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...Sheetaleventcompany
 
Presentation on Engagement in Book Clubs
Presentation on Engagement in Book ClubsPresentation on Engagement in Book Clubs
Presentation on Engagement in Book Clubssamaasim06
 
Navi Mumbai Call Girls Service Pooja 9892124323 Real Russian Girls Looking Mo...
Navi Mumbai Call Girls Service Pooja 9892124323 Real Russian Girls Looking Mo...Navi Mumbai Call Girls Service Pooja 9892124323 Real Russian Girls Looking Mo...
Navi Mumbai Call Girls Service Pooja 9892124323 Real Russian Girls Looking Mo...Pooja Nehwal
 
ANCHORING SCRIPT FOR A CULTURAL EVENT.docx
ANCHORING SCRIPT FOR A CULTURAL EVENT.docxANCHORING SCRIPT FOR A CULTURAL EVENT.docx
ANCHORING SCRIPT FOR A CULTURAL EVENT.docxNikitaBankoti2
 
OSCamp Kubernetes 2024 | A Tester's Guide to CI_CD as an Automated Quality Co...
OSCamp Kubernetes 2024 | A Tester's Guide to CI_CD as an Automated Quality Co...OSCamp Kubernetes 2024 | A Tester's Guide to CI_CD as an Automated Quality Co...
OSCamp Kubernetes 2024 | A Tester's Guide to CI_CD as an Automated Quality Co...NETWAYS
 
Night 7k Call Girls Noida Sector 128 Call Me: 8448380779
Night 7k Call Girls Noida Sector 128 Call Me: 8448380779Night 7k Call Girls Noida Sector 128 Call Me: 8448380779
Night 7k Call Girls Noida Sector 128 Call Me: 8448380779Delhi Call girls
 
Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...
Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...
Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...Hasting Chen
 
Andrés Ramírez Gossler, Facundo Schinnea - eCommerce Day Chile 2024
Andrés Ramírez Gossler, Facundo Schinnea - eCommerce Day Chile 2024Andrés Ramírez Gossler, Facundo Schinnea - eCommerce Day Chile 2024
Andrés Ramírez Gossler, Facundo Schinnea - eCommerce Day Chile 2024eCommerce Institute
 
Exploring protein-protein interactions by Weak Affinity Chromatography (WAC) ...
Exploring protein-protein interactions by Weak Affinity Chromatography (WAC) ...Exploring protein-protein interactions by Weak Affinity Chromatography (WAC) ...
Exploring protein-protein interactions by Weak Affinity Chromatography (WAC) ...Salam Al-Karadaghi
 
Mathematics of Finance Presentation.pptx
Mathematics of Finance Presentation.pptxMathematics of Finance Presentation.pptx
Mathematics of Finance Presentation.pptxMoumonDas2
 
George Lever - eCommerce Day Chile 2024
George Lever -  eCommerce Day Chile 2024George Lever -  eCommerce Day Chile 2024
George Lever - eCommerce Day Chile 2024eCommerce Institute
 

Recently uploaded (20)

Governance and Nation-Building in Nigeria: Some Reflections on Options for Po...
Governance and Nation-Building in Nigeria: Some Reflections on Options for Po...Governance and Nation-Building in Nigeria: Some Reflections on Options for Po...
Governance and Nation-Building in Nigeria: Some Reflections on Options for Po...
 
Thirunelveli call girls Tamil escorts 7877702510
Thirunelveli call girls Tamil escorts 7877702510Thirunelveli call girls Tamil escorts 7877702510
Thirunelveli call girls Tamil escorts 7877702510
 
Call Girl Number in Khar Mumbai📲 9892124323 💞 Full Night Enjoy
Call Girl Number in Khar Mumbai📲 9892124323 💞 Full Night EnjoyCall Girl Number in Khar Mumbai📲 9892124323 💞 Full Night Enjoy
Call Girl Number in Khar Mumbai📲 9892124323 💞 Full Night Enjoy
 
CTAC 2024 Valencia - Sven Zoelle - Most Crucial Invest to Digitalisation_slid...
CTAC 2024 Valencia - Sven Zoelle - Most Crucial Invest to Digitalisation_slid...CTAC 2024 Valencia - Sven Zoelle - Most Crucial Invest to Digitalisation_slid...
CTAC 2024 Valencia - Sven Zoelle - Most Crucial Invest to Digitalisation_slid...
 
Call Girls in Sarojini Nagar Market Delhi 💯 Call Us 🔝8264348440🔝
Call Girls in Sarojini Nagar Market Delhi 💯 Call Us 🔝8264348440🔝Call Girls in Sarojini Nagar Market Delhi 💯 Call Us 🔝8264348440🔝
Call Girls in Sarojini Nagar Market Delhi 💯 Call Us 🔝8264348440🔝
 
BDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort Service
 
WhatsApp 📞 9892124323 ✅Call Girls In Juhu ( Mumbai )
WhatsApp 📞 9892124323 ✅Call Girls In Juhu ( Mumbai )WhatsApp 📞 9892124323 ✅Call Girls In Juhu ( Mumbai )
WhatsApp 📞 9892124323 ✅Call Girls In Juhu ( Mumbai )
 
CTAC 2024 Valencia - Henrik Hanke - Reduce to the max - slideshare.pdf
CTAC 2024 Valencia - Henrik Hanke - Reduce to the max - slideshare.pdfCTAC 2024 Valencia - Henrik Hanke - Reduce to the max - slideshare.pdf
CTAC 2024 Valencia - Henrik Hanke - Reduce to the max - slideshare.pdf
 
Open Source Strategy in Logistics 2015_Henrik Hankedvz-d-nl-log-conference.pdf
Open Source Strategy in Logistics 2015_Henrik Hankedvz-d-nl-log-conference.pdfOpen Source Strategy in Logistics 2015_Henrik Hankedvz-d-nl-log-conference.pdf
Open Source Strategy in Logistics 2015_Henrik Hankedvz-d-nl-log-conference.pdf
 
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...
 
Presentation on Engagement in Book Clubs
Presentation on Engagement in Book ClubsPresentation on Engagement in Book Clubs
Presentation on Engagement in Book Clubs
 
Navi Mumbai Call Girls Service Pooja 9892124323 Real Russian Girls Looking Mo...
Navi Mumbai Call Girls Service Pooja 9892124323 Real Russian Girls Looking Mo...Navi Mumbai Call Girls Service Pooja 9892124323 Real Russian Girls Looking Mo...
Navi Mumbai Call Girls Service Pooja 9892124323 Real Russian Girls Looking Mo...
 
ANCHORING SCRIPT FOR A CULTURAL EVENT.docx
ANCHORING SCRIPT FOR A CULTURAL EVENT.docxANCHORING SCRIPT FOR A CULTURAL EVENT.docx
ANCHORING SCRIPT FOR A CULTURAL EVENT.docx
 
OSCamp Kubernetes 2024 | A Tester's Guide to CI_CD as an Automated Quality Co...
OSCamp Kubernetes 2024 | A Tester's Guide to CI_CD as an Automated Quality Co...OSCamp Kubernetes 2024 | A Tester's Guide to CI_CD as an Automated Quality Co...
OSCamp Kubernetes 2024 | A Tester's Guide to CI_CD as an Automated Quality Co...
 
Night 7k Call Girls Noida Sector 128 Call Me: 8448380779
Night 7k Call Girls Noida Sector 128 Call Me: 8448380779Night 7k Call Girls Noida Sector 128 Call Me: 8448380779
Night 7k Call Girls Noida Sector 128 Call Me: 8448380779
 
Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...
Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...
Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...
 
Andrés Ramírez Gossler, Facundo Schinnea - eCommerce Day Chile 2024
Andrés Ramírez Gossler, Facundo Schinnea - eCommerce Day Chile 2024Andrés Ramírez Gossler, Facundo Schinnea - eCommerce Day Chile 2024
Andrés Ramírez Gossler, Facundo Schinnea - eCommerce Day Chile 2024
 
Exploring protein-protein interactions by Weak Affinity Chromatography (WAC) ...
Exploring protein-protein interactions by Weak Affinity Chromatography (WAC) ...Exploring protein-protein interactions by Weak Affinity Chromatography (WAC) ...
Exploring protein-protein interactions by Weak Affinity Chromatography (WAC) ...
 
Mathematics of Finance Presentation.pptx
Mathematics of Finance Presentation.pptxMathematics of Finance Presentation.pptx
Mathematics of Finance Presentation.pptx
 
George Lever - eCommerce Day Chile 2024
George Lever -  eCommerce Day Chile 2024George Lever -  eCommerce Day Chile 2024
George Lever - eCommerce Day Chile 2024
 

Presentation: eSubmissions in Australia - Part 2

  • 1. eSubmissions in Australia Part 2 Dr John Donohoe Director, Knowledge Management Section Office of Medicines Authorisation 16 December 2014
  • 2. Regional Content • Module 1 administrative and prescribing information • Module 2.3.R and 3.2.R regional information – 2.3.R should provide a brief description of the information provided under 3.2.R – Applicants should include the following information in Module 3.2.R, where appropriate: § Process validation scheme for the drug product § Certificates of suitability § Risk of transmitting animal spongiform encephalopathy agents § Certified Product Details § Supplier’s declarations regarding compliance with packaging standards and colouring standards. eSubmissions in Australia 1
  • 3. Node Extensions • A way of providing extra organisational information to the eCTD. • Visualised as an extra heading in the CTD structure. • Displayed as extra headings when the XML backbone is viewed. • Node-extension structure is in compliance with general ICH eCTD specifications • Example: Grouping multiple files belonging to a single study – 5312 (eCTD Section) § Study ABC123 • Synopsis.pdf • Report Body.pdf • Discontinued Patient Listing.pdf § Study XYZ321 • Synopsis.pdf • Report Body.pdf • Discontinued Patient Listing.pdf – 537 CRFs § Study ABC123 ‒ Site 123 • CRF-123-0001.pdf • CRF-123-0002.pdf ‒ Site 234 • CRF-234-0001.pdf • CRF-234-0002.pdf eSubmissions in Australia 2
  • 4. Node Extensions and Leaf Elements • Structures beyond the heading elements can be defined through node extension elements. • Content for each heading element is provided through leaf elements. • Wherever a leaf element is allowed in the schema, a node-extension element is also allowed. • The optional node-extension element contains a single mandatory title element, followed by at least one leaf element. • The node extension title element and leaf title element should be short, precise and informative. – Information already categorized by heading elements need not be repeated. – The most important identifying information should be placed at the beginning to prevent reviewers from having to scroll to the end of the title. eSubmissions in Australia 3
  • 5. Node Extensions • Node Extension structures should be considered and used where needed to assist reviewers • Consider the impact of changing node extension structures during the lifecycle • Don’t use where ICH specified sub headings already exist • Only use at the lowest level of the eCTD structure • Use to group together multiple like documents • Node extensions may be nested • Node extensions content can be placed in separate sub folders eSubmissions in Australia 4
  • 6. Leaf Titles • The display name given to a document and will be shown to the evaluator • An evaluator never sees the file/folder names in the file structure • Leaf titles should not include: – file extensions, e.g. appendix1.pdf – hyphens or underscores, e.g. copy-certification.pdf – eCTD section number. The eCTD application has “life cycle” and contains the history of all your submissions! eSubmissions in Australia 5
  • 7. Study Tagging Files • A structured solution to organizing studies in eCTD applications providing a consistent structure for review and categorisation of clinical and nonclinical studies. • Comprised of an XML Backbone file with category information and links to study content. • Content tags based on ICH E3 Guidance on the Structure of Clinical Studies. • Predefined values for Species, Route of Administration, Duration and Type of Control. • TGA does not currently have any plans to mandate study tagging files (STFs) for evaluation purposes. • Applicants wishing to reuse content submitted in other regions where STFs have been used can do so. • If provided, STFs will be validated and must be conform to standards and specifications. eSubmissions in Australia 6
  • 8. Regional File Formats • Module 1 – Both PDF and XML have been designated as acceptable file formats for the AU Module 1. – No structured exchange (XML) standards for content are currently defined – These may be introduced in the future for content such as the lifecycle management tracking table, application forms, etc. – All PDF files included in an eCTD irrespective of the module should be v1.4, v1.5, v1.6 or v1.7 except where a specific requirement for a later version is defined – It is preferred that PDFs be generated from an electronic source. Signatures may be embedded as a graphic file in the PDF text if desired. • Modules 2 to 5 - No additional file formats are defined for Modules 2 to 5 other than those mentioned in the ICH eCTD Specification Document. eSubmissions in Australia 7
  • 9. Use of Electronic Signatures • Currently the use of digital signatures for electronic submissions is not fully supported within the TGA. • Scanned signatures would ordinarily be used where the documents make up part of the checksum of an eCTD submission. eSubmissions in Australia 8
  • 10. Handling of Empty or Missing eCTD Sections • For new applications, including generic applications, detailed statements justifying the absence of data or specific CTD sections should be provided in the relevant Quality Overall Summary and/or Nonclinical/Clinical Overviews e.g. Module 2.3, 2.4, or 2.5. • For a generic application, there is no need to provide a justification for content that is typically absent. • Note that placeholder documents highlighting no relevant content should not be placed in the eCTD structure. eSubmissions in Australia 9
  • 11. Updating Backbone Attributes • Updating ICH attributes – Updating XML backbone attributes such as manufacturer during the eCTD lifecycle is possible. – Consideration should be given regarding the impact of changing backbone attributes during the lifecycle. – Changes can lead to a higher level of complexity in the cumulative view of a submission. • Updating AU envelope information – The AU envelope information can be updated during the lifecycle as is necessary to reflect changes in the application metadata. eSubmissions in Australia 10
  • 12. File Reuse • TGA accepts and encourages applicants to make active use of file reuse. • Applicants should not submit the same document multiple times. • File reuse should be used when – a file is submitted multiple times within one sequence, – a file already submitted in an earlier sequence is being referenced again, – or if a file submitted in another application is being referenced in a new application. • TGA is implementing a flat repository structure to make cross application referencing possible. – Links to content provided in other applications simply need to be directed out of the current application structure and into the structure of the corresponding application. – All application will be stored using the eSubmission Identifier to make cross referencing easily predictable and possible. eSubmissions in Australia 11
  • 13. Module 1 Architecture The AU Module 1 Backbone File and Style-Sheet • The Australian Module 1 is schema based instead of using a dtd. • The Australian Module 1 eCTD backbone file comprises three main components: – A fixed eXtensible Markup Language (XML) root element; – The envelope elements; and – The eCTD heading elements describing the actual files provided. • Style-Sheet – A standard style-sheet is provided that can be used to view content – The style-sheet has been designed to display the complete Module 1 – The style-sheet is not part of the specification package – eCTD applications can be submitted with or without the style-sheet – The TGA will not be reviewing content using the style-sheet – Its existence is not part of the validation criteria eSubmissions in Australia 12
  • 14. Module 1 Architecture XML Root Element • All Australian Module 1 backbone files prepared for the TGA will contain the standard XML root element • The required text includes an XML declaration and the root element tga_ectd with its attributes linking the XML file to the XML definition prepared by the TGA • Without style-sheet: •With style-sheet: eSubmissions in Australia 13
  • 15. Envelope Elements • What are Envelope Elements? – Administrative information imbedded into a sequence which helps to identify and categorise the content, also for automated processes. XML Element Description Constraint Occurrence Defined List esub-id eSubmission Identifier Mandatory Single applicant Applicant Mandatory Single aan Australian Approved Name(s) Mandatory Multiple product-name Product Name Mandatory Multiple artg-number ARTG Number Optional Multiple sequence-description Sequence Description Mandatory Single X sequence-number Sequence Number Mandatory Single related-sequence-number Related Sequence Number Optional Single reg-activity-lead Regulatory Activity Lead Mandatory Single X sequence-type Sequence Type Mandatory Single X eSubmissions in Australia 14
  • 16. Envelope Elements: Defined Lists • The defined lists are provided and maintained as separate XML files • Each file contains a standard set of codes for the corresponding envelope element. • Codes have been implemented to reduce validation issues • The code definition files contain a version number, version date and coded values as well as plain texts for each value. • Only the plain text value is shown to the reviewers in the review system. • Defined lists have been created for – Sequence Description – Regulatory Activity Lead – Sequence Type eSubmissions in Australia 15
  • 17. Envelope Elements: Sequence Description • The sequence description defined list of codes and values is available from http://tga.gov.au/downloads/sequence-description.xml. Applicants should refer to this list for current list values. • There are 4 types of sequence description approaches – Some values can be used without further information – Others will require the description to be combined with a date – In the example with the PSUR, both the start date and the end date have to be entered – Finally, some descriptions will need additional information added in the form of a brief description (brief – under 40 characters) eSubmissions in Australia 16
  • 18. Envelope Elements Sequence Description Example 1 Some values can be used without further information e.g. Initial. – The code for “Initial” is seq-desc-2 as specified in the defined list – Note that the code version must be specified as an attribute code-version of the sequence-description element. eSubmissions in Australia 17
  • 19. Envelope Elements Sequence Description Example 2 Others will require the description to be combined with a date e.g. Response to Screening Clarification Request – 2014-03-30. – The code for a response to a screening clarification request is seq-desc-5 as specified in the defined list – Response to Screening Clarification Request - {date:d} – A date is required as additional data. The name of the placeholder is date. It requires an actual value in date format (because of the letter d following the colon). eSubmissions in Australia 18
  • 20. Envelope Elements Sequence Description Example 3 In the example with the PSUR, both the start date and the end date will have to be entered e.g. PSUR for Period of 2015-01-01 to 2015-06-30. – The code for “PSUR” is seq-desc-20 as specified in the defined list – PSUR for Period of {from-date:d} to {to-date:d} – Two placeholders have been specified. The first one is named from-date and the second one is named to-date eSubmissions in Australia 19
  • 21. Envelope Elements Sequence Description Example 4 Finally, some descriptions will need additional information added in the form of a brief description (brief – under 40 characters) e.g. Uncategorised, DESCRIPTION. – The code for “uncategorized” is seq-desc-24 as specified in the defined list – Uncategorised, {description:s} – The name of the placeholder is description. It requires an actual value in plain text format which is indicated by the letter “s” following the colon. eSubmissions in Australia 20
  • 22. Envelope Elements Regulatory Activity Lead The regulatory activity lead defined list of codes and values is managed at http://tga.gov.au/downloads/reg-activity-lead.xml. Applicants should refer to this list for current list values. The code for “Prescription” is reg-act-lead-6 as specified in the defined list Note that the code version must be specified as an attribute code-version of the reg-activity-lead element. eSubmissions in Australia 21
  • 23. Envelope Elements Sequence Type The sequence type defined list of codes and values is available from http://tga.gov.au/downloads/sequence-type.xml. Applicants should refer to this list for current list values. The code for “New chemical entities” is seq-type-1 as specified in the defined list Note that the code version must be specified as an attribute code-version of the sequence-type element. eSubmissions in Australia 22
  • 24. Heading Elements What are Heading Elements? • Each specified section of the eCTD is associated with a heading element which is used to identify and organise the content associated with that section. eSubmissions in Australia 23
  • 25. Heading Elements Section ID Business Terminology XML-Element 1.0 Correspondence m1-0-correspondence 1.0.1 Cover letter m1-0-1-cover 1.0.2 Lifecycle management tracking table m1-0-2-tracking-table 1.0.3 Response to request for information m1-0-3-response 1.2 Administrative Information m1-2-admin-info 1.2.1 Application forms m1-2-1-app-form 1.2.2 Pre-submission details m1-2-2-pre-sub-details 1.2.3 Patent certification m1-2-3-pat-cert 1.2.4 Change in sponsor m1-2-4-change-sponsor 1.3 Medicine information and labelling m1-3-med-info 1.3.1 Product information and package insert m1-3-1-pi 1.3.1.1 Product information - clean m1-3-1-1-pi-clean 1.3.1.2 Product information - annotated m1-3-1-2-pi-annotated 1.3.1.3 Package insert m1-3-1-3-pack-ins 1.3.2 Consumer medicines information m1-3-2-cmi 1.3.2.1 Consumer medicines information - clean m1-3-2-1-cmi-clean 1.3.2.2 Consumer medicines information - annotated m1-3-2-2-cmi-annotated 1.3.3 Label mock-ups and specimens m1-3-3-mockup Section ID Business Terminology XML-Element 1.4 Information about the experts m1-4-experts 1.4.1 Quality m1-4-1-quality 1.4.2 Nonclinical m1-4-2-nonclinical 1.4.3 Clinical m1-4-3-clinical 1.5 Specific requirements for different types of applications m1-5-specific 1.5.1 Literature-based submission documents m1-5-1-lit-based 1.5.2 Orphan drug designation m1-5-2-orphan 1.5.3 Genetically modified organisms consents m1-5-3-gmo 1.5.4 Additional trade name declarations m1-5-4-trade-name 1.5.5 Co-marketed medicines declarations m1-5-5-co-marketed 1.5.6 Combination medicine consent m1-5-6-comb-med 1.5.7 OTC product assurances m1-5-7-prod-assurance 1.5.8 Analytical validation summary m1-5-8-analyt-val-sum 1.6 Master files and certificates of suitability m1-6-master-files 1.6.1 Relevant external sources m1-6-1-ext-sources 1.6.2 Applicant's declaration m1-6-2-app-decl 1.6.3 Letters of access m1-6-3-loa eSubmissions in Australia 24
  • 26. Heading Elements Section ID Business Terminology XML-Element 1.7 Compliance with meetings and pre- submission processes m1-7-compliance 1.7.1 Details of compliance with pre-submission meeting outcomes m1-7-1-pre-sub 1.7.2 Details of any additional data to be submitted m1-7-2-add-data 1.7.3 Declaration of compliance with pre-submission planning form and planning letter m1-7-3-planning 1.8 Information relating to pharmacovigilance m1-8-pv 1.8.1 Pharmacovigilance systems m1-8-1-pv-systems 1.8.2 Risk management plan m1-8-2-risk 1.9 Summary of biopharmaceutic studies m1-9-biopharm 1.9.1 Summary of bioavailability or bioequivalence study m1-9-1-ba-be 1.9.2 Justification for not providing biopharmaceutic studies m1-9-2-justification 1.10 Information relating to paediatrics m1-10-paediatrics 1.11 Foreign regulatory information m1-11-foreign 1.11.1 Foreign regulatory status m1-11-1-status 1.11.2 Foreign product information m1-11-2-pi 1.11.3 Data similarities and differences m1-11-3-similarities 1.11.4 Foreign evaluation reports m1-11-4-eval-reports 1.12 Antibiotic resistance data m1-12-antibiotic eSubmissions in Australia 25
  • 27. Module 1 Architecture Files and Folders • Naming conventions for the content files are irrelevant for electronic review. • All content must be referenced by the appropriate XML files for efficient navigation. • Applicants should concentrate on providing precise but informative leaf titles to aid reviewers. Folder File Description e123456 Application folder with eSubmission identifier e.g. e123456 0000 Sequence folder with four digit sequence number e.g. 0000 index.xml Index file in accordance with ICH index-md5.txt MD5 checksum in accordance with ICH m1 Content folder for Module 1 documents in accordance with ICH au Australia country specific folder au-regional.xml Australia regional index file for Module 1 m2 Content folder for Module 2 documents in accordance with ICH m3 Content folder for Module 3 documents in accordance with ICH m4 Content folder for Module 4 documents in accordance with ICH m5 Content folder for Module 5 documents in accordance with ICH util Util folder in accordance with ICH dtd DTD and schema folder in accordance with ICH au-regional.xsd Australia regional backbone schema for Module 1 xlink.xsd W3C schema for XLink 1.1 (referenced from au-regional.xsd) xml.xsd W3C schema for XML namespace (referenced from au-regional.xsd) ich-ectd-3-2.dtd ICH DTD for Modules 2 to 5 style Style sheet folder in accordance with ICH (optional) ectd-2-0.xsl ICH style sheet for Modules 2 to 5 (optional) au-regional.xsl Style sheet for Australian regional backbone (optional) 0000-validation-report Comprehensive output from an eCTD validation tool eSubmissions in Australia 26
  • 28. The Final Take Away Consider Your Audience: •If you were the evaluator and you are not familiar with the submission, could you easily navigate the submission and do an efficient review? •Perform an overall QC after compiling the submission. •Navigate the submission using eCTD TOC tree, leaf titles, links, and bookmarks keeping the evaluator in mind. •Use a QC process or checklist to help ensure submissions don’t contain formatting issues. •Good planning and being proactive can help you avoid the need to respond to queries, send resubmissions, and send additional corrective submissions to fix formatting issues! eSubmissions in Australia 27